ABG Compensation 2026: Stryker Hip Settlement Payouts and Claim Status
Quick Answer
- What it is: Compensation for patients implanted with recalled Stryker ABG II or Rejuvenate modular hip stems.
- How much: Base awards of $300,000 per failed hip, plus enhancements for complications.
- Key deadline: Enrollment closed for most programs. Unrevised plaintiffs face tolling deadlines and 2026 discovery extensions.
When you see the letters “ABG” tied to compensation, context matters entirely. In legal circles, ABG most often refers to the Stryker ABG II Modular Neck Hip Stem, a device recalled in 2012 after reports of corrosion and tissue damage. But ABG also appears in employment disputes, media litigation, and even clinical acid-base interpretation.
This guide focuses on the ABG compensation that matters for patients: the Stryker hip implant settlement. It breaks down verified payout structures, who may still qualify, and where unresolved claims stand in 2026.
The Facts
| Topic | What You Need to Know |
|---|---|
| Case Name | In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation |
| Court | U.S. District Court for the District of Minnesota (MDL No. 13-2441) |
| Device Recalled | July 2012, Stryker Rejuvenate and ABG II Modular Neck Hip Stems |
| Base Award | $300,000 per failed implant (2014 global settlement) |
| Total Settlement Value | Estimated $1.4 billion (2014 program) |
| Eligibility | Revision surgery patients; certain unrevised patients with tolling agreements |
| Claims Processor | GCG (contact via official settlement website) |
| Current Status | Active discovery extensions through December 2026 for some matters |
What Is the ABG Compensation for Stryker Hip Implants?
ABG compensation refers to the settlement program for patients harmed by the recalled Stryker ABG II Modular Neck Hip Stem. The device was recalled in July 2012 due to fretting and corrosion at the neck-stem junction.
The corrosion released metal debris into surrounding tissue, causing metallosis, necrosis, pain, and the need for revision surgery. Stryker agreed to a global settlement program in November 2014, valued at approximately $1.4 billion.
The compensation structure was designed to move quickly. Base awards of $300,000 per failed implant were described as the largest ever in failed hip replacement litigation at that time. Additional compensation was available for patients who suffered complications during revision surgery or required future surgeries.
The settlement was uncapped for Stryker, meaning the total payout depended on how many eligible patients enrolled. Over 95% of eligible patients participated in the 2014 program, and a subsequent 2016 program enrolled 96% of additional eligible patients.
ABG Compensation Chart: Payout Tiers and Award Structure
The ABG compensation chart is not a single public document with fixed dollar amounts for every scenario. The 2014 settlement established base awards and enhancement categories, but individual payouts varied based on specific complications and damages.
Here is the verified award structure:
| Award Category | Amount | Eligibility |
|---|---|---|
| Base Award | $300,000 per failed hip | Revision surgery patients |
| Complications Enhancement | Variable | Patients with complications during revision |
| Future Surgeries | Variable | Patients requiring additional procedures |
| Unrevised (Infirm) Benefit | One-time payment | Medically unable to undergo revision |
| 2016 Program Base | Same structure | Newly eligible revision patients |
The exact dollar amounts for enhancements were determined case by case. The settlement agreement did not publish a fixed chart with every possible combination of complications and payments.
A plain-life comparison: think of the base award like the sticker price on a car. The enhancements are the options package. Your final number depends on what you actually needed.
Who Qualifies for ABG II Hip Settlement Compensation?
You may qualify if you were implanted with a Stryker ABG II or Rejuvenate modular neck hip stem and underwent revision surgery within the specified timeframes. The original 2014 program covered surgeries before November 3, 2014.
The 2016 program expanded eligibility to patients who had revision surgery before December 19, 2016. Patients who were eligible for the 2014 program but did not enroll could join the 2016 program.
For patients who needed a revision but were medically unable to undergo surgery, the settlement created a one-time benefit under the Covered Unrevised, Infirm Patient Program.
Key eligibility criteria include:
- Device implanted: Stryker ABG II or Rejuvenate Modular Neck Hip Stem
- Revision surgery: Removal of the implant within the covered timeframe
- Medical documentation: Proof of implantation and revision
- Enrollment: Registered by the applicable deadline for each program
If you are unsure whether your hip implant was affected, check your operative report. The device name will be listed.
Reality Check: No settlement administrator will text you asking for a fee to release your ABG compensation. The claims process is free. Third-party “claim helpers” charging upfront fees are unnecessary and often predatory.
How to File an ABG Compensation Claim
The enrollment deadlines for the primary Stryker settlement programs have passed. The 2014 program required enrollment by early 2015, and the 2016 program closed in 2017.
If you missed those deadlines, you cannot enroll retroactively. However, patients with pending lawsuits or tolling agreements may still have options.
Here is the process that applied during open enrollment:
- Register on the official settlement website: Provide your implant and revision details.
- Obtain your operative report: This document proves the device model and revision surgery.
- Complete the Enrollment Claim Form: Submit before the stated deadline.
- Submit the Stipulation of Dismissal: Required only if you had a filed lawsuit.
- Wait for claim review: The Claims Processor reviewed each submission.
- Receive award determination: Base award plus any applicable enhancements.
- Payment distribution: Checks issued after review completion.
For unrevised plaintiffs with tolling agreements, the process differs. You must wait until revision surgery occurs, then move to reopen your case within the tolling period.
What Is the Current Status of Stryker ABG II Litigation in 2026?
The Stryker ABG II litigation is not fully closed. While the main settlement programs have concluded, residual matters remain active in New Jersey and Minnesota courts.
In June 2026, the Superior Court of New Jersey extended discovery in certain Stryker ABG matters through December 31, 2026. This extension applies to cases where discovery was set to expire on or about June 30, 2026.
In the federal MDL in Minnesota, Judge Donovan Frank dismissed one case without prejudice in April 2026 after the plaintiffs failed to respond to a court order regarding settlement program eligibility. That dismissal allows for refiling if circumstances change.
As of February 2026, approximately 2,054 cases remained pending in the hip implant litigation space, though this figure covers multiple manufacturers, not only Stryker.
The takeaway: if you have an unresolved ABG II claim, it is not forgotten. Courts are still managing the docket.
Key Takeaway: The main Stryker ABG II settlement programs have closed, but tolling agreements and pending cases keep the litigation active through at least December 2026.
ABG Group Legal Matters: The Other ABG Compensation Dispute
There is a separate ABG legal matter involving Authentic Brands Group (ABG) and Sports Illustrated. This is not related to hip implants.
In April 2024, ABG and its affiliates filed a breach of contract action against The Arena Group and Manoj Bhargava in the U.S. District Court for the Southern District of New York. The dispute concerned the termination of the Sports Illustrated licensing agreement.
ABG sought damages of approximately $48.75 million ($3.75 million in royalty fees and $45 million in termination fees). The Arena Group filed counterclaims alleging unfair competition, misappropriation of trade secrets, and tortious interference.
On April 29, 2025, the parties entered a confidential settlement resolving all claims. The financial impact was reflected in The Arena Group’s financial statements for the quarter ending June 30, 2025.
If you are searching for “ABG compensation” and you worked for or with Authentic Brands Group, this is the relevant dispute. It is a corporate contract matter, not a consumer class action.
ABG Compensation in Employment Contexts
ABG also appears as an employer acronym in employment disputes. A 2016 forum post on LawyersClubIndia described a former employee of ABG Group (ABG Shipyard) seeking unpaid final dues of $7,664.
That matter involved a defense sales executive placed in Sierra Leone who alleged the company cut his salary and failed to remit final payments. The post is a single user’s account and does not represent a verified legal proceeding.
The broader lesson: if you are searching for “ABG compensation” in an employment context, verify the full company name. ABG Shipyard, Authentic Brands Group, and Stryker’s ABG II hip device are completely separate entities.
What Happens Next for Unresolved ABG II Claims
Pending ABG II matters will continue through discovery and resolution into 2027. Here is the expected sequence:
Through December 31, 2026: Extended discovery period for certain New Jersey matters.
Expected Q1 2027: Discovery closes for cases under the June 2026 extension.
Expected Q2 2027: Dispositive motions and potential trial dates for remaining cases.
Ongoing: Tolling agreements remain in effect for unrevised plaintiffs until revision surgery occurs.
Ongoing: Settlement program administration continues for any late-arising eligibility questions.
Frequently Asked Questions
What is the average ABG compensation payout?
Base awards were $300,000 per failed hip implant. Additional enhancements varied by complication type. The total settlement exceeded $1 billion.
Can I still file a Stryker ABG II claim in 2026?
The main enrollment periods closed in 2015 and 2017. However, patients with tolling agreements or pending lawsuits may still have options. Consult an attorney about your specific situation.
What was the ABG II hip implant recall?
Stryker recalled the ABG II and Rejuvenate modular neck hip stems in July 2012. The devices caused corrosion at the neck-stem junction, releasing metal debris and requiring revision surgery.
How do I check my ABG compensation claim status?
Contact the Claims Processor at GCG. The toll-free number is 1-855-382-6404, or email [email protected].
Is the ABG settlement the same as the Rejuvenate settlement?
Yes, they were combined. Stryker settled both the ABG II and Rejuvenate hip stem claims under one global program.
What is the deadline for unrevised ABG II plaintiffs?
It depends on your tolling agreement. Generally, tolling extends until revision surgery occurs, plus one year, or until ten years after implantation, whichever is sooner.
Did anyone go to trial for ABG II hip implants?
Most cases settled. The 2014 global settlement resolved thousands of claims before trial. Some residual matters continue in discovery as of 2026.
What is the ABG Group settlement with Sports Illustrated?
A separate corporate dispute. ABG settled with The Arena Group in April 2025 over the terminated Sports Illustrated licensing agreement. Terms were confidential.
Closing
If you had a Stryker ABG II or Rejuvenate hip implant, your window for the main settlement programs has closed. But unresolved claims and tolling agreements remain active. Check your operative report to confirm the device, and contact the Claims Processor or an attorney if you believe you still have a claim. The $300,000 base award is the anchor of this compensation program.
